MediWound Ltd. (MDWD) Stock Forecast
MDWD analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.83 / 5 from 6 analysts
- Price target
- $30.67 average of analyst targets
- Upside to target
- +158.8% from the latest close
- Next earnings
- November 19, 2026 EPS estimate $-0.66
- 52-week range
- $11.85 – $19.69
MDWD analyst ratings
6 analystsNumber of analysts at each rating.
MDWD price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
MDWD earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.73 | −$0.92 | −$0.62 | −$0.24 | −202.5% | 5 |
| Current fiscal year (2026) | −$2.23 | −$2.71 | −$1.98 | −$2.10 | −6.2% | 5 |
| Next fiscal year (2027) | −$2.29 | −$2.80 | −$2.00 | −$2.23 | −2.7% | 5 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
MDWD revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $6.7M | $5.7M | $8.2M | +23.9% | 6 |
| Current fiscal year (2026) | $23.7M | $21.1M | $25.3M | +39.6% | 6 |
| Next fiscal year (2027) | $31.8M | $29.6M | $34.0M | +34.3% | 6 |
MDWD EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
MDWD revenue: reported and forecast
MDWD EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.71 | −$0.71 | −$0.73 | −$0.73 | −$0.73 | +2.8% | 2 up · 3 down |
| Current fiscal year (2026) | −$2.38 | −$2.38 | −$2.23 | −$2.23 | −$2.23 | −6.5% | 3 up · 1 down |
| Next fiscal year (2027) | −$2.22 | −$2.22 | −$2.29 | −$2.29 | −$2.29 | +3.2% | 1 up · 4 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
MDWD earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; MDWD beat in 7 of 12.
What analysts expect from MDWD
6 analysts cover MediWound; their consensus rating is strong buy (4.83 on a 1–5 scale, where 5 is a strong buy). The average price target is $30.67, 158.8% above the latest close of $11.85. Analysts expect earnings of −$2.23 per share for 2026, −6.2% from a year earlier. For 2027 the average estimate is −$2.29 per share on revenue of $31.8 million. MediWound beat the EPS estimate in 7 of the last 12 quarters.
Related: MDWD income statement, MDWD key metrics, MDWD chart. See the MDWD stock overview for the latest quote and news.
MDWD forecast FAQ
What is MediWound's price target?
The average analyst price target for MediWound is $30.67, 158.8% above the latest close of $11.85.
Is MediWound a buy, hold or sell?
Of 6 analysts covering MediWound, 5 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is MediWound's EPS forecast?
Analysts forecast −$2.23 per share for 2026 (range −$2.71 to −$1.98); for 2027 the estimate is −$2.29.
What is MediWound's revenue forecast?
The average revenue estimate for 2026 is $23.7 million, growth of 39.6%; for 2027 it is $31.8 million.
When does MediWound report earnings?
MediWound is expected to report results for the quarter ending September 30, 2026 on November 19, 2026 before the market opens; the EPS estimate is $-0.66.
Does MediWound usually beat earnings estimates?
MediWound reported EPS at or above the analyst estimate in 7 of the last 12 quarters.